1-3 of 3
Andy I Chen, MDPhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Updated Results of a Phase II Randomized Study (ROMULUS) of Polatuzumab Vedotin or Pinatuzumab Vedotin Plus Rituximab in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Franck Morschhauser, MD PhD, Ian Flinn, Ranjana H Advani, MD, Catherine S. Diefenbach, MD, Kathryn Kolibaba, MD, Oliver W. Press, MD PhD, Laurie H Sehn, MD MPH, Andy I Chen, MDPhD, Gilles Salles, MD PhD, Herve Tilly, MD, Bruce D. Cheson, MD, Sarit Assouline, MD MSc, Martin Dreyling, Anton Hagenbeek, MD PhD, Pier Luigi Zinzani, MD, Sreeni Yalamanchili, BSPharm, Dan Lu, PhD, Cheryl Jones, PhD, Surai Jones, PhD, Yu-Waye Chu, Jeff P. Sharman, MD
Journal: Blood
Blood (2014) 124 (21): 4457.
https://doi.org/10.1182/blood.V124.21.4457.4457
Published: 2014
Journal Articles

The Aethera Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma

Craig H. Moskowitz, MD, Auayporn Nadamanee, MD, Tamas Masszi, MD PhD, Edward Agura, MD, Jerzy Holowiecki, MD PhD, Muneer H. Abidi, MD, Andy I Chen, MDPhD, Patrick J. Stiff, MD, Alessandro M. Gianni, MD, Angelo M. Carella, MD, Dzhelil Osmanov, MD, Veronika Bachanova, MD, John Sweetenham, MD, Anna Sureda, Dirk Huebner, MD, Emily K. Larsen, MS, Naomi N.H. Hunder, MD, Jan Walewski
Journal: Blood
Blood (2014) 124 (21): 673.
https://doi.org/10.1182/blood.V124.21.673.673
Published: 2014
Journal Articles

Consolidative Autologous Stem Cell Transplant for Double Hit Lymphoma

Andy I Chen, MDPhD, Craig Okada, MD PhD, Nate Gay, MD, Phil Reiss, MD, Stephen Spurgeon, MD, Guang Fan, MD PhD, Rita M. Braziel, MD, Richard T. Maziarz, MD
Journal: Blood
Blood (2014) 124 (21): 3993.
https://doi.org/10.1182/blood.V124.21.3993.3993
Published: 2014